The Evil Within

We have seen over the last few years the extreme pressure that the American healthcare system

has had on a large number of Americans. Insurance companies have been cracking down and

tightening their leashes around the necks of so many of us. An evil that lies among the American

healthcare system is one that has grown tenfold with COVID-19, and is starting to lay in more

not only to the American people but also their pocket books. I of course am speaking of the

American Pharmaceutical companies.

According to the American Society of Plumbing Engineers (ASPE), “Over the period from

January 2022 to January 2023, more than 4,200 drug products had price increases, of which 46

percent were larger than the rate of inflation. The average drug price increase over the course of

the period was 15.2 percent, which translates to $590 per drug product.” Drug prices in America

are on a continual rise, and the pharmaceutical companies are continuing to raise prices and

shutting out a large number of lower classes from receiving their proper medical care.

Within the United States the pharmaceutical companies have close to zero regulation on what

they want to set their prices at. This allows them free creative ability to move and shape the

market how they see fit. The only thing that has been done to put pressure on them has been

under President Joe Biden and his capping of the price of insulin at 35 dollars.

There are a number of reasons as to the causes of such little regulation of the pharmaceutical

industry, but the three main ones are: the formation of political iron triangles, the constant battle

to make a profit, and the hold they hold over a number of different patent laws. These three

things put together is the reason why this industry is a formidable force upon the American

political system and on the everyday American.

Let us examine the first pillar to their power: political iron triangles. If you are not familiar with

the term Iron triangle it is a term that refers to when a company or interest group has control of a

person working in the government and through them has control of bureaucracy and law making.

The pharmaceutical industry is an industry that has control of roughly two-thirds of congress

whether that be through supporting their campaigns financially or through lobbying efforts. They

have become fully entrenched in American bureaucracy, and is a large reason as to why they are

still so unregulated even today. They have complete freedom to run amuck over the American

consumers. The lax nature of their regulation also allows them to use practices that are harmful

or unsafe when it comes to the testing and development of new drugs within the consumer

market. This allows them to push out drugs at higher rates to continue to cushion profit margins

and have more money in their pockets.

The second pillar that holds up this industry is their constant drive to profit over all else. Prices

have remained high because corporate CEO’s are driven to the idea of making sure that they

continue to hold dominance over the market. The most profitable pharmaceutical company Pfizer

saw a seven percent increase over 2023 bringing in over 14 billion dollars over the

fourth quarter. Even with the hardships that have been facing the American economy we are still

seeing companies break record high profit margins across a number of industries, not just in the

pharmaceutical industry. It is hard to blame them for being driven by profit just because that is

the nature of the American capitalist society, but when it is still coming at the cost of the

American consumers who are struggling, and hurting then it is time we begin to call out these

companies for the hurt they are causing.

Finally, the last pillar that rounds out the trifecta that solidifies the liquid steel that is this industry

is the hold they have on US patent laws. A quick explanation of how US pharmaceutical patent

laws work, in simplistic terms it is the idea of when a company has a patent on a drug that means

only that company can manufacture and sell that drug. What does that do to the American

consumer? What it does is keep us locked in to prices for certain drugs. That connection with

American insurance companies leads to someone like me who only pays a co-pay of four dollars

for a medication that might be 15 dollars for someone else. There is an extreme price gouging

issue when it comes to medications that leads to so many Americans in lower class statuses

having to go without certain medications because they are locked behind patent pay walls.